Henry Ginsberg, MD
Endocrinology, Diabetes & Metabolism · New York, NYNPI 1356406268
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $117,732 of the $160,884 with a category attached, or 73.2%. 21 manufacturers reported payments, led by Merck at 37.9% of the total. Reporting peaked in 2019 at $44,448 and has fallen 77.6% since, to $9,970 in 2025. Among endocrinology, diabetes & metabolism clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 117 payments — averaging $1375.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$61K
- Kowa Research Institute, Inc.$52K
- Amgen$15K
- Ionis Pharmaceuticals, Inc.$8K
- Boehringer Ingelheim International GmbH$4K
- Astrazeneca AB$4K
- plus $18K from 15 others
Across 20 payments — averaging $42,962 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$420K
- Pfizer$213K
- Amgen$209K
- Regeneron$9K
- Ionis Pharmaceuticals, Inc.$7K
- Sanofi-aventis U.S. LLC$1K
What the payments were for
- Consulting fees$117,73273%
- Speaking & faculty fees$15,87210%
- Travel & lodging$25,16016%
- Food & beverage$2,0231%
- Education$970%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 53 | $60,958 |
| Kowa Research Institute, Inc. | 14 | $51,574 |
| Amgen | 13 | $14,765 |
| Ionis Pharmaceuticals, Inc. | 12 | $8,469 |
| Boehringer Ingelheim International GmbH | 1 | $3,716 |
| Astrazeneca AB | 1 | $3,600 |
| Sanofi-aventis U.S. LLC | 1 | $3,490 |
| Janssen Research & Development, LLC | 1 | $3,000 |
| Regeneron | 1 | $2,140 |
| Intercept Pharmaceuticals, Inc. | 1 | $2,100 |
| Novo Nordisk | 4 | $1,409 |
| Mirum Pharmaceuticals, Inc. | 1 | $1,300 |
| Astrazeneca UK Limited | 1 | $1,074 |
| KOWA Company, LTD. | 1 | $1,000 |
| Novo Nordisk AS | 1 | $850 |
| Pfizer | 2 | $767 |
| Novartis | 3 | $184 |
| BETA Bionics, Inc. | 2 | $158 |
| Kowa Pharmaceuticals America, Inc. | 2 | $146 |
| Esperion Therapeutics, Inc. | 1 | $118 |
| Eli Lilly | 1 | $65 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$8,866
- OLEZARSEN$8,166
- JARDIANCE$3,716
- PRALUENT$3,490
- EVKEEZA$2,140
- CTEXLI$1,300
- iLet Bionic Pancreas$403
- MK-3655$337
- iLet Insulin Infusion Kit Inset$134
- iLet Insulin Infusion Kit Contact Detach$134
- ENTRESTO$131
- LEQVIO$131
- NEXLETOL$118
How this compares
$160,884 in reported general payments places this provider in the 95th percentile of 804 endocrinology, diabetes & metabolism providers in New York.
See all endocrinology, diabetes & metabolism providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in New York
- John BilezikianNew York$809K
- Anastasios ManessisNew York$656K
- Jason BakerNew York$427K
- Brian LevyNew York$417K
- Stuart WeissNew York$275K
- Priya JaisinghaniNew York$239K
- Recaredo BerbanoNew York$146K
- Beverly TchangNew York$120K
- Shira EytanNew York$96K
- Minisha SoodNew York$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.